APO Research

APO RESEARCH · REPORT

Biorepository Services

Selected research

Market Analysis & Forecast

Global Biorepository Services Market Analysis and Forecast 2026-2032

Market perspective

The global Biorepository Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biorepository Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biorepository Services include Azenta, EPL Archives (VWR), Q2 Lab Solutions, Medpace Labs, Thermo Fisher Scientific, Clinigen, Precision Stability Storage, Precision for Medicine and Kryosphere, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biorepository Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biorepository Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biorepository Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biorepository Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biorepository Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biorepository Services revenue, projected growth trends, production technology, application and end-user industry.

Biorepository Services Segment by Company

Azenta

EPL Archives (VWR)

Q2 Lab Solutions

Medpace Labs

Thermo Fisher Scientific

Clinigen

Precision Stability Storage

Precision for Medicine

Kryosphere

Cryoport Inc

Masy BioServices (Alcami)

SciSafe (BioLife Solutions)

Cenetron (Versiti Clinical Trials)

Vigilant Bioservices

CellCarta

BioArkive

Tescor

Birka BioStorag

Shanghai Biochip Co

Albetra

Biorepository Services Segment by Type

Room Temperature Storage

Refrigerated Storage

Frozen Storage

Ultra Low Temperature Storage

Liquid Nitrogen Storage

Others

Biorepository Services Segment by Application

Life Sciences

Hospital

Research Institutions

Chemical Industry

Others

Biorepository Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biorepository Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biorepository Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biorepository Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biorepository Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biorepository Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biorepository Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biorepository Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Room Temperature Storage Major Player Table 3. Refrigerated Storage Major Player Table 4. Frozen Storage Major Player Table 5. Ultra Low Temperature Storage Major Player Table 6. Liquid Nitrogen Storage Major Player Table 7. Others Major Player Table 8. Global Biorepository Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Life Sciences Major Player Table 10. Hospital Major Player Table 11. Research Institutions Major Player Table 12. Chemical Industry Major Player Table 13. Others Major Player Table 14. Biorepository Services Industry Trends Table 15. Biorepository Services Industry Drivers Table 16. Biorepository Services Industry Opportunities and Challenges Table 17. Biorepository Services Industry Restraints Table 18. Global Biorepository Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Biorepository Services Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Biorepository Services Market Share by Region (2021-2026) Table 21. Global Biorepository Services Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Biorepository Services Market Share by Region (2027-2032) Table 23. Global Biorepository Services Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Biorepository Services Revenue Market Share by Players (2021-2026) Table 25. Global Biorepository Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Biorepository Services Key Players Headquarters & Area Served Table 27. Global Biorepository Services Players, Product Type & Application Table 28. Global Biorepository Services Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Biorepository Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Biorepository Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Biorepository Services Revenue Market Share by Type (2021-2026) Table 35. Global Biorepository Services Revenue Market Share by Type (2027-2032) Table 36. Global Biorepository Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Biorepository Services Revenue Market Share by Application (2021-2026) Table 40. Global Biorepository Services Revenue Market Share by Application (2027-2032) Table 41. Azenta Company Information Table 42. Azenta Business Overview Table 43. Azenta Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Azenta Biorepository Services Product Portfolio Table 45. Azenta Recent Development Table 46. EPL Archives (VWR) Company Information Table 47. EPL Archives (VWR) Business Overview Table 48. EPL Archives (VWR) Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. EPL Archives (VWR) Biorepository Services Product Portfolio Table 50. EPL Archives (VWR) Recent Development Table 51. Q2 Lab Solutions Company Information Table 52. Q2 Lab Solutions Business Overview Table 53. Q2 Lab Solutions Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Q2 Lab Solutions Biorepository Services Product Portfolio Table 55. Q2 Lab Solutions Recent Development Table 56. Medpace Labs Company Information Table 57. Medpace Labs Business Overview Table 58. Medpace Labs Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Medpace Labs Biorepository Services Product Portfolio Table 60. Medpace Labs Recent Development Table 61. Thermo Fisher Scientific Company Information Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Thermo Fisher Scientific Biorepository Services Product Portfolio Table 65. Thermo Fisher Scientific Recent Development Table 66. Clinigen Company Information Table 67. Clinigen Business Overview Table 68. Clinigen Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Clinigen Biorepository Services Product Portfolio Table 70. Clinigen Recent Development Table 71. Precision Stability Storage Company Information Table 72. Precision Stability Storage Business Overview Table 73. Precision Stability Storage Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Precision Stability Storage Biorepository Services Product Portfolio Table 75. Precision Stability Storage Recent Development Table 76. Precision for Medicine Company Information Table 77. Precision for Medicine Business Overview Table 78. Precision for Medicine Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Precision for Medicine Biorepository Services Product Portfolio Table 80. Precision for Medicine Recent Development Table 81. Kryosphere Company Information Table 82. Kryosphere Business Overview Table 83. Kryosphere Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Kryosphere Biorepository Services Product Portfolio Table 85. Kryosphere Recent Development Table 86. Cryoport Inc Company Information Table 87. Cryoport Inc Business Overview Table 88. Cryoport Inc Biorepository Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Cryoport Inc Biorepository Services Product Portfolio Table 90. Cryoport Inc Recent Development Table 91. Masy BioServices (Alcami) Company Information Table 92. Masy BioServices (Alcami) Business Overview Table 93. Masy BioServices (Alcami) Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Masy BioServices (Alcami) Biorepository Services Product Portfolio Table 95. Masy BioServices (Alcami) Recent Development Table 96. SciSafe (BioLife Solutions) Company Information Table 97. SciSafe (BioLife Solutions) Business Overview Table 98. SciSafe (BioLife Solutions) Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SciSafe (BioLife Solutions) Biorepository Services Product Portfolio Table 100. SciSafe (BioLife Solutions) Recent Development Table 101. Cenetron (Versiti Clinical Trials) Company Information Table 102. Cenetron (Versiti Clinical Trials) Business Overview Table 103. Cenetron (Versiti Clinical Trials) Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio Table 105. Cenetron (Versiti Clinical Trials) Recent Development Table 106. Vigilant Bioservices Company Information Table 107. Vigilant Bioservices Business Overview Table 108. Vigilant Bioservices Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Vigilant Bioservices Biorepository Services Product Portfolio Table 110. Vigilant Bioservices Recent Development Table 111. CellCarta Company Information Table 112. CellCarta Business Overview Table 113. CellCarta Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. CellCarta Biorepository Services Product Portfolio Table 115. CellCarta Recent Development Table 116. BioArkive Company Information Table 117. BioArkive Business Overview Table 118. BioArkive Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. BioArkive Biorepository Services Product Portfolio Table 120. BioArkive Recent Development Table 121. Tescor Company Information Table 122. Tescor Business Overview Table 123. Tescor Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Tescor Biorepository Services Product Portfolio Table 125. Tescor Recent Development Table 126. Birka BioStorag Company Information Table 127. Birka BioStorag Business Overview Table 128. Birka BioStorag Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Birka BioStorag Biorepository Services Product Portfolio Table 130. Birka BioStorag Recent Development Table 131. Shanghai Biochip Co Company Information Table 132. Shanghai Biochip Co Business Overview Table 133. Shanghai Biochip Co Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Shanghai Biochip Co Biorepository Services Product Portfolio Table 135. Shanghai Biochip Co Recent Development Table 136. Albetra Company Information Table 137. Albetra Business Overview Table 138. Albetra Biorepository Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Albetra Biorepository Services Product Portfolio Table 140. Albetra Recent Development Table 141. North America Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Biorepository Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Biorepository Services Revenue by Country (2021-2026) & (US$ Million) Table 147. North America Biorepository Services Revenue by Country (US$ Million) & (2027-2032) Table 148. Europe Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Biorepository Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Biorepository Services Revenue by Country (2021-2026) & (US$ Million) Table 154. Europe Biorepository Services Revenue by Country (US$ Million) & (2027-2032) Table 155. China Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 156. China Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 157. China Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 158. China Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 162. Asia Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 163. Asia Biorepository Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Biorepository Services Revenue by Region (US$ Million) & (2021-2026) Table 165. Asia Biorepository Services Revenue by Region (US$ Million) & (2027-2032) Table 166. SAMEA Biorepository Services Revenue by Type (2021-2026) & (US$ Million) Table 167. SAMEA Biorepository Services Revenue by Type (2027-2032) & (US$ Million) Table 168. SAMEA Biorepository Services Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Biorepository Services Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Biorepository Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Biorepository Services Revenue by Country (2021-2026) & (US$ Million) Table 172. SAMEA Biorepository Services Revenue by Country (US$ Million) & (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Biorepository Services Image Figure 2. Global Biorepository Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biorepository Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Room Temperature Storage Image Figure 5. Refrigerated Storage Image Figure 6. Frozen Storage Image Figure 7. Ultra Low Temperature Storage Image Figure 8. Liquid Nitrogen Storage Image Figure 9. Others Image Figure 10. Global Biorepository Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Biorepository Services Market Size Share 2021 VS 2025 VS 2032 Figure 12. Life Sciences Image Figure 13. Hospital Image Figure 14. Research Institutions Image Figure 15. Chemical Industry Image Figure 16. Others Image Figure 17. Global Biorepository Services Market Size (US$ Million) & (2021-2032) Figure 18. Global Biorepository Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Biorepository Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Biorepository Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Biorepository Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Biorepository Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Biorepository Services Revenue Market Share by Type (2021-2032) Figure 25. Global Biorepository Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Biorepository Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Biorepository Services Revenue Market Share by Application (2021-2032) Figure 28. North America Biorepository Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Biorepository Services Revenue Share by Type (2021-2032) Figure 30. North America Biorepository Services Revenue Share by Application (2021-2032) Figure 31. North America Biorepository Services Revenue Share by Country (2021-2032) Figure 32. United States Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Biorepository Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Biorepository Services Revenue Share by Type (2021-2032) Figure 37. Europe Biorepository Services Revenue Share by Application (2021-2032) Figure 38. Europe Biorepository Services Revenue Share by Country (2021-2032) Figure 39. Germany Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Biorepository Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Biorepository Services Revenue Share by Type (2021-2032) Figure 49. China Biorepository Services Revenue Share by Application (2021-2032) Figure 50. Asia Biorepository Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Biorepository Services Revenue Share by Type (2021-2032) Figure 52. Asia Biorepository Services Revenue Share by Application (2021-2032) Figure 53. Asia Biorepository Services Revenue Share by Region (2021-2032) Figure 54. Japan Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Biorepository Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Biorepository Services Revenue Share by Type (2021-2032) Figure 62. SAMEA Biorepository Services Revenue Share by Application (2021-2032) Figure 63. SAMEA Biorepository Services Revenue Share by Country (2021-2032) Figure 64. Brazil Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Biorepository Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Room Temperature Storage
  • Refrigerated Storage
  • Frozen Storage
  • Ultra Low Temperature Storage
  • Liquid Nitrogen Storage
  • Others
Applications
  • Life Sciences
  • Hospital
  • Research Institutions
  • Chemical Industry
  • Others
Companies covered
  • Azenta
  • EPL Archives (VWR)
  • Q2 Lab Solutions
  • Medpace Labs
  • Thermo Fisher Scientific
  • Clinigen
  • Precision Stability Storage
  • Precision for Medicine
  • Kryosphere
  • Cryoport Inc
  • Masy BioServices (Alcami)
  • SciSafe (BioLife Solutions)
  • Cenetron (Versiti Clinical Trials)
  • Vigilant Bioservices
  • CellCarta
  • BioArkive
  • Tescor
  • Birka BioStorag
  • Shanghai Biochip Co
  • Albetra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biorepository Services Market by Type
  3. 1.2.1 Global Biorepository Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Room Temperature Storage
  5. 1.2.3 Refrigerated Storage
  6. 1.2.4 Frozen Storage
  7. 1.2.5 Ultra Low Temperature Storage
  8. 1.2.6 Liquid Nitrogen Storage
  9. 1.2.7 Others
  10. 1.3 Biorepository Services Market by Application
  11. 1.3.1 Global Biorepository Services Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Life Sciences
  13. 1.3.3 Hospital
  14. 1.3.4 Research Institutions
  15. 1.3.5 Chemical Industry
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Biorepository Services Market Dynamics
  1. 2.1 Biorepository Services Industry Trends
  2. 2.2 Biorepository Services Industry Drivers
  3. 2.3 Biorepository Services Industry Opportunities and Challenges
  4. 2.4 Biorepository Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biorepository Services Market Perspective (2021-2032)
  2. 3.2 Global Biorepository Services Growth Trends by Region
  3. 3.2.1 Global Biorepository Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biorepository Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Biorepository Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biorepository Services Revenue by Players
  2. 4.1.1 Global Biorepository Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Biorepository Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biorepository Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biorepository Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biorepository Services Key Players Headquarters & Area Served
  7. 4.4 Global Biorepository Services Players, Product Type & Application
  8. 4.5 Global Biorepository Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biorepository Services Market CR5 and HHI
  11. 4.6.3 2025 Biorepository Services Tier 1, Tier 2, and Tier 3
5 Biorepository Services Market Size by Type
  1. 5.1 Global Biorepository Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biorepository Services Revenue by Type (2021-2032)
  3. 5.3 Global Biorepository Services Revenue Market Share by Type (2021-2032)
6 Biorepository Services Market Size by Application
  1. 6.1 Global Biorepository Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biorepository Services Revenue by Application (2021-2032)
  3. 6.3 Global Biorepository Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Azenta
  2. 7.1.1 Azenta Company Information
  3. 7.1.2 Azenta Business Overview
  4. 7.1.3 Azenta Biorepository Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Azenta Biorepository Services Product Portfolio
  6. 7.1.5 Azenta Recent Developments
  7. 7.2 EPL Archives (VWR)
  8. 7.2.1 EPL Archives (VWR) Company Information
  9. 7.2.2 EPL Archives (VWR) Business Overview
  10. 7.2.3 EPL Archives (VWR) Biorepository Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 EPL Archives (VWR) Biorepository Services Product Portfolio
  12. 7.2.5 EPL Archives (VWR) Recent Developments
  13. 7.3 Q2 Lab Solutions
  14. 7.3.1 Q2 Lab Solutions Company Information
  15. 7.3.2 Q2 Lab Solutions Business Overview
  16. 7.3.3 Q2 Lab Solutions Biorepository Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Q2 Lab Solutions Biorepository Services Product Portfolio
  18. 7.3.5 Q2 Lab Solutions Recent Developments
  19. 7.4 Medpace Labs
  20. 7.4.1 Medpace Labs Company Information
  21. 7.4.2 Medpace Labs Business Overview
  22. 7.4.3 Medpace Labs Biorepository Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Medpace Labs Biorepository Services Product Portfolio
  24. 7.4.5 Medpace Labs Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific Biorepository Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific Biorepository Services Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Clinigen
  32. 7.6.1 Clinigen Company Information
  33. 7.6.2 Clinigen Business Overview
  34. 7.6.3 Clinigen Biorepository Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Clinigen Biorepository Services Product Portfolio
  36. 7.6.5 Clinigen Recent Developments
  37. 7.7 Precision Stability Storage
  38. 7.7.1 Precision Stability Storage Company Information
  39. 7.7.2 Precision Stability Storage Business Overview
  40. 7.7.3 Precision Stability Storage Biorepository Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Precision Stability Storage Biorepository Services Product Portfolio
  42. 7.7.5 Precision Stability Storage Recent Developments
  43. 7.8 Precision for Medicine
  44. 7.8.1 Precision for Medicine Company Information
  45. 7.8.2 Precision for Medicine Business Overview
  46. 7.8.3 Precision for Medicine Biorepository Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Precision for Medicine Biorepository Services Product Portfolio
  48. 7.8.5 Precision for Medicine Recent Developments
  49. 7.9 Kryosphere
  50. 7.9.1 Kryosphere Company Information
  51. 7.9.2 Kryosphere Business Overview
  52. 7.9.3 Kryosphere Biorepository Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kryosphere Biorepository Services Product Portfolio
  54. 7.9.5 Kryosphere Recent Developments
  55. 7.10 Cryoport Inc
  56. 7.10.1 Cryoport Inc Company Information
  57. 7.10.2 Cryoport Inc Business Overview
  58. 7.10.3 Cryoport Inc Biorepository Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cryoport Inc Biorepository Services Product Portfolio
  60. 7.10.5 Cryoport Inc Recent Developments
  61. 7.11 Masy BioServices (Alcami)
  62. 7.11.1 Masy BioServices (Alcami) Company Information
  63. 7.11.2 Masy BioServices (Alcami) Business Overview
  64. 7.11.3 Masy BioServices (Alcami) Biorepository Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Masy BioServices (Alcami) Biorepository Services Product Portfolio
  66. 7.11.5 Masy BioServices (Alcami) Recent Developments
  67. 7.12 SciSafe (BioLife Solutions)
  68. 7.12.1 SciSafe (BioLife Solutions) Company Information
  69. 7.12.2 SciSafe (BioLife Solutions) Business Overview
  70. 7.12.3 SciSafe (BioLife Solutions) Biorepository Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SciSafe (BioLife Solutions) Biorepository Services Product Portfolio
  72. 7.12.5 SciSafe (BioLife Solutions) Recent Developments
  73. 7.13 Cenetron (Versiti Clinical Trials)
  74. 7.13.1 Cenetron (Versiti Clinical Trials) Company Information
  75. 7.13.2 Cenetron (Versiti Clinical Trials) Business Overview
  76. 7.13.3 Cenetron (Versiti Clinical Trials) Biorepository Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio
  78. 7.13.5 Cenetron (Versiti Clinical Trials) Recent Developments
  79. 7.14 Vigilant Bioservices
  80. 7.14.1 Vigilant Bioservices Company Information
  81. 7.14.2 Vigilant Bioservices Business Overview
  82. 7.14.3 Vigilant Bioservices Biorepository Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Vigilant Bioservices Biorepository Services Product Portfolio
  84. 7.14.5 Vigilant Bioservices Recent Developments
  85. 7.15 CellCarta
  86. 7.15.1 CellCarta Company Information
  87. 7.15.2 CellCarta Business Overview
  88. 7.15.3 CellCarta Biorepository Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CellCarta Biorepository Services Product Portfolio
  90. 7.15.5 CellCarta Recent Developments
  91. 7.16 BioArkive
  92. 7.16.1 BioArkive Company Information
  93. 7.16.2 BioArkive Business Overview
  94. 7.16.3 BioArkive Biorepository Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BioArkive Biorepository Services Product Portfolio
  96. 7.16.5 BioArkive Recent Developments
  97. 7.17 Tescor
  98. 7.17.1 Tescor Company Information
  99. 7.17.2 Tescor Business Overview
  100. 7.17.3 Tescor Biorepository Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Tescor Biorepository Services Product Portfolio
  102. 7.17.5 Tescor Recent Developments
  103. 7.18 Birka BioStorag
  104. 7.18.1 Birka BioStorag Company Information
  105. 7.18.2 Birka BioStorag Business Overview
  106. 7.18.3 Birka BioStorag Biorepository Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Birka BioStorag Biorepository Services Product Portfolio
  108. 7.18.5 Birka BioStorag Recent Developments
  109. 7.19 Shanghai Biochip Co
  110. 7.19.1 Shanghai Biochip Co Company Information
  111. 7.19.2 Shanghai Biochip Co Business Overview
  112. 7.19.3 Shanghai Biochip Co Biorepository Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Shanghai Biochip Co Biorepository Services Product Portfolio
  114. 7.19.5 Shanghai Biochip Co Recent Developments
  115. 7.20 Albetra
  116. 7.20.1 Albetra Company Information
  117. 7.20.2 Albetra Business Overview
  118. 7.20.3 Albetra Biorepository Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Albetra Biorepository Services Product Portfolio
  120. 7.20.5 Albetra Recent Developments
8 North America
  1. 8.1 North America Biorepository Services Revenue (2021-2032)
  2. 8.2 North America Biorepository Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Biorepository Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Biorepository Services Revenue by Type (2027-2032)
  5. 8.3 North America Biorepository Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Biorepository Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Biorepository Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Biorepository Services Revenue by Application (2027-2032)
  9. 8.5 North America Biorepository Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Biorepository Services Revenue by Country
  11. 8.6.1 North America Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biorepository Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Biorepository Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biorepository Services Revenue (2021-2032)
  2. 9.2 Europe Biorepository Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biorepository Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biorepository Services Revenue by Type (2027-2032)
  5. 9.3 Europe Biorepository Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biorepository Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biorepository Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biorepository Services Revenue by Application (2027-2032)
  9. 9.5 Europe Biorepository Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biorepository Services Revenue by Country
  11. 9.6.1 Europe Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biorepository Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biorepository Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biorepository Services Revenue (2021-2032)
  2. 10.2 China Biorepository Services Revenue by Type (2021-2032)
  3. 10.2.1 China Biorepository Services Revenue by Type (2021-2026)
  4. 10.2.2 China Biorepository Services Revenue by Type (2027-2032)
  5. 10.3 China Biorepository Services Revenue Share by Type (2021-2032)
  6. 10.4 China Biorepository Services Revenue by Application (2021-2032)
  7. 10.4.1 China Biorepository Services Revenue by Application (2021-2026)
  8. 10.4.2 China Biorepository Services Revenue by Application (2027-2032)
  9. 10.5 China Biorepository Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biorepository Services Revenue (2021-2032)
  2. 11.2 Asia Biorepository Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biorepository Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biorepository Services Revenue by Type (2027-2032)
  5. 11.3 Asia Biorepository Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biorepository Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biorepository Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biorepository Services Revenue by Application (2027-2032)
  9. 11.5 Asia Biorepository Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biorepository Services Revenue by Country
  11. 11.6.1 Asia Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biorepository Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biorepository Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biorepository Services Revenue (2021-2032)
  2. 12.2 SAMEA Biorepository Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biorepository Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biorepository Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biorepository Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biorepository Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biorepository Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biorepository Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biorepository Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biorepository Services Revenue by Country
  11. 12.6.1 SAMEA Biorepository Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biorepository Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biorepository Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research